- £4.57m
- £3.45m
REG - ValiRx PLC - Proposed Appointment of Non-Executive Director
AnnouncementREG - ValiRx PLC - Half-year Report
AnnouncementREG - ValiRx PLC - Shareholder Communications
AnnouncementREG - ValiRx PLC - Holding(s) in Company
AnnouncementREG - ValiRx PLC - Successful evaluation of breast cancer programme
AnnouncementREG - ValiRx PLC - Director/PDMR Shareholding
AnnouncementREG - AIM - AIM Notice - 07/07/2022
AnnouncementREG - ValiRx PLC - Holding(s) in Company
AnnouncementREG - ValiRx PLC - Broker Option Results
AnnouncementREG - ValiRx PLC - Result of AGM and Appointment of Joint Broker
AnnouncementREG - ValiRx PLC - Extends exclusivity period for TheoremRx
AnnouncementREG - ValiRx PLC - Issue of Equity
AnnouncementREG - ValiRx PLC - Update on VAL201 sub-license agreement
AnnouncementREG - ValiRx PLC - Annual Report, AGM Notice & Director Resignation
AnnouncementREG - ValiRx PLC - Update on proposed sub-license of VAL201
AnnouncementREG - ValiRx PLC - Operational and Strategy Update
AnnouncementREG - ValiRx PLC - Evaluation agreement with University of Barcelona
AnnouncementREG - ValiRx PLC - Second Price Monitoring Extn
AnnouncementREG - ValiRx PLC - Price Monitoring Extension
Announcement